Anaphylaxis News and Research

RSS

Anaphylaxis is an acute multi-system severe type I hypersensitivity reaction. Due in part to the variety of definitions, between 1% and 15% of the population of the United States can be considered "at risk" for having an anaphylactic reaction if they are exposed to one or more allergens. Of those people who actually experience anaphylaxis, up to 1% may die as a result.

Holidays linked to severe spike in nut allergies among children

A new study examining the link between peanut and tree-nut anaphylaxis in children and holidays found spikes at Halloween and Easter.

5 Oct 2020

Allergic immune response against bacteria is not pathological but protective

Allergy is one of the most common diseases in Europe, it is estimated that more than 150 million Europeans suffer from recurring allergies and by 2025 this could have increased to half of the entire European population.

9 Sep 2020

Inflammatory protein produced by mast cells contributes to fibrosis in gastric cancer

Gastric cancer, one of the leading causes of cancer-associated mortality worldwide, is renowned for its ability to disseminate throughout the peritoneal cavity.

26 Aug 2020

Cognitive behavioral therapy helps food allergic children with severe phobia of anaphylaxis

Imagine a young girl with a peanut allergy, so stricken by fear of anaphylaxis that she no longer takes part in everyday activities many children take for granted.

28 Jul 2020

Human genome may explain the neonatal origins of chronic immune and inflammatory diseases

A study published in the journal Nature Communications has pinpointed a number of areas of the human genome that may help explain the neonatal origins of chronic immune and inflammatory diseases of later life, including type 1 diabetes, rheumatoid arthritis and coeliac disease.

28 Jul 2020

Pandemic-inspired food labeling raises alarms for those with food allergies

As the mother of a child with food allergies, Heather Sapp was well versed in reading labels and calling manufacturers to verify ingredients. For years, she kept her daughter's diet free of the peanuts and tree nuts that could kill her.

21 Jul 2020

New drug can prevent life-threatening anaphylaxis, shows study

For someone with a food or drug allergy, the risk of life-threatening anaphylactic shock lurks around every corner. A new Northwestern Medicine study shows there might be a pill that can be taken proactively to prevent mild to life-threatening anaphylaxis, no matter the cause.

3 Jun 2020

Study may help to improve diagnosis and treatment of allergies

Results from a study led by investigators at Massachusetts General Hospital may help to improve the diagnosis and treatment of allergies, pointing to a potential marker of these conditions and a new therapeutic strategy.

20 May 2020

The nutritional key to control autoimmunity and cancer

Scientists at the Department of Infection and Immunity of the Luxembourg Institute of Health revealed a novel mechanism through which the immune system can control autoimmunity and cancer.

8 May 2020

Milk allergy - is it overdiagnosed?

A new review published in the journal JAMA Pediatrics in April 2020 raises the concern that there may be a significant overdiagnosis of cow's milk allergy in babies and young children, stemming from the use of current medical recommendations.

13 Apr 2020

Milk allergy guidelines may be linked to overdiagnosis in babies and children

Current medical guidelines for diagnosing cow's milk allergy in babies and young children may be linked to overdiagnosis of the condition.

13 Apr 2020

Transferring knowledge, not anxiety, can help food-allergic children cope with their fears

A new article in Annals of Allergy, Asthma and Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology discusses the difficulties faced by parents of children with food allergies in not transferring their own anxieties to their children.

25 Feb 2020

Brisbane’s grass pollen season the worst on record, says QUT professor

Brisbane’s grass pollen levels over the past two months have been up to four times higher than levels recorded anywhere in Australia since comparative records have been kept, QUT’s Professor Janet Davies told a federal parliamentary inquiry this week.

20 Feb 2020

FDA approves first oral immunotherapy treatment for peanut allergy in children, teens

The University of Chicago Medicine was part of a landmark clinical trial that led to approval by the U.S. Food and Drug Administration of the first oral immunotherapy treatment for peanut allergy in children and teens.

13 Feb 2020

FDA-approved OIT product marks major milestone in management of peanut allergies

In February 2020, the U.S. Food and Drug Administration (FDA) approved Palforzia, the first peanut powder product designed to help reduce the risk of severe peanut-induced allergic reactions through desensitization over time.

4 Feb 2020

People with peanut allergies avoid tree nuts despite being non-allergic to them

A new study reveals that 4 in 10 people who have peanut allergies choose not to consume tree nuts, despite not having allergies to these nuts. The study titled, “Real world tree nut consumption in peanut-allergic individuals,” was published in Annals of Allergy, Asthma and Immunology in the latest issue. The journal is the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI).

19 Dec 2019